On September 14, 2018, Bittirov, A. M.; Kabardiev, S. Sh.; Begieva, S. A.; Kabardiev, Sh. S.; Bittirov, I. A.; Karpushchenko, K. A.; Bittirova, A. A. published a patent.Computed Properties of 86393-32-0 The title of the patent was Ointment type panpharmacon for complex treatment of animal eye diseases and method of producing thereof. And the patent contained the following:
This invention relates to the field of veterinary medicine and an ointment-type panpharmacon for the complex treatment of cattle thelaziosis, complicated by staphylococci, streptococci, chlamydia, Pseudomonas aeruginosa, Hemophilus spp., comprising ciprofloxacin hydrochloride monohydrate, and is characterized in that it contains micronized fenbendazole having a particle size of 25-50 μ, and as an ointment base – an alloy of petrolatum of “”eye ointments”” type and lanolin anhydrous, and a preservative – Nipasol, the components in the agent being in a certain ratio in mass %, per 100 g of ointment. The invention provides an expansion of the arsenal of means for local treatment of cattle thelaziosis, complicated by staphylococci, streptococci, chlamydia, Pseudomonas aeruginosa, Hemophilus spp. The experimental process involved the reaction of 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate(cas: 86393-32-0).Computed Properties of 86393-32-0
The Article related to ointment eye thelaziosis bacterial infection anthelmintic bactericide, Pharmaceuticals: Formulation and Compounding and other aspects.Computed Properties of 86393-32-0
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics